Gateway for:

Member Countries

Projects

#1033Spider Web Proteins for Medicine

Obtaining and Strucutal-Functional Investigations of Spider Web Recombinant Proteins and their Synthetic Analogs for the Purpose of the Development of New Materials Designed for Medical Application

#1033.2Spider Web Proteins for Medicine

Obtaining and Structural-Functional Investigations of Spider Web Recombinant Proteins and Their Synthetic Analogs for the Purpose of the Development of New Materials Designed for Medical Application

#1038SELEX is Structure-Function Studies of Cytokines

Exploiting of SELEX Procedure in Structure-Function Studies of Recombinant Human Cytokines and Their Natural and Synthetic Antagonists in Order to Create Artificial Immunomodulating Medical Preparations

#1066Utilization of Heavy Water

Utilization of Heavy Water of Nuclear Industry in Biology and Medicine

#1163New Bioinsecticide

Development of the Technology for Production of New Bioinsecticide and Aerosol Equipment for its Effective Utilization

#2734Cholinesterase for Prophylactics of Poisoning by Organophosphorous Inhibitors

The Production of Highly Active Human Blood Plasma Butyrylcholinesterase Preparation by Gene Engineering Methods to Create Protective Means against Poisoning by Organophosphorous Cholinesterase Inhibitors

#2750Study of Prion Proteins using Relevant Aptamers

Study of Prion Proteins using Relevant Aptamers, Obtained by SELEX, Aimed to Develop New Approaches in Diagnostics and Therapy of Prion-Mediated Diseases

#2915.2Human Alpha-Fetoprotein for Anticancer Therapy

Development of the Biotechnology of the Yeast Recombinant Alpha-Fetoprotein: Design of the Highly Specific Anticancer Drug for the Tumor-Selective Triggering of Apoptosis

#2972Fungicide for the Protection of Cereal

The Development of Biological Fungicide for the Protection of Cereal Against Phytopathogenic Fungi

#3350Biological Surface-Active Substance

Development of biological preparation with surfactant activity

#3729Pseudomonas aeruginosa Bacteriophages

Antimicrobial Activity of Bacteriophages and Their Lytic Products in Respect to Pseudomonas aeruginosa Clinical Isolates